An exemplary move

Klein, Ed
August 2002
Westchester County Business Journal;8/5/2002, Vol. 41 Issue 31, p37
Presents an update on the business activities of area public companies in Westchester County, New York State whose stocks have remained stable despite confusion among investors as of August 2002. Certification of corporate reports by Drew Industries; Amount to be paid by Bayer Diagnostics for Visible Genetics Inc. for the development of an HIV drug; Trial on the safety of Interleukin-1 by Regeneron Pharmaceuticals Inc.


Related Articles

  • Pharmaceutical and chemical giant finds 'a third way'.  // Personnel Today;11/12/2002, p29 

    Focuses on an approach developed by a chemical and pharmaceutical group Bayer Diagnostics to meet the future needs of its business. Basis of the approach; Survey conducted by Bayer Diagnostics to determine its employee's attitude; Feedback program conducted by managers and supervisors.

  • Analyze This. Hoffman, Mala // Westchester County Business Journal;1/13/2003, Vol. 42 Issue 2, pT1 

    Focuses on the launch of Complexed PSA (cPSA) test for the fight against prostate cancer by Bayer Diagnostics in Tarrytown, New York. Innovation in medical technology and pharmaceutical development; Creation of sophisticated diagnostic devices; Approval of the cPSA test by the Food and Drug...

  • Products, innovations and productivity. Dunham, Dottie // MLO: Medical Laboratory Observer;Nov2003, Vol. 35 Issue 11, p22 

    Interviews Bayer Diagnostics president and physician Wolfgang Hartwig concerning the challenges of the company. Health care products provided by the firm; Testing, information and services of Bayer Diagnostics in response to bioterrorism; Effect of the shortage of clinical laboratory...

  • Former Bayer plant ready for tech tenants to set up shop. Soder, Chuck // Crain's Cleveland Business;1/14/2008, Vol. 29 Issue 2, p3 

    The article reports that the owner of the Oberlin, Ohio-based plant of the pharmaceutical company Bayer Diagnostics, Kevin Flanigan, has started recruiting young technology companies and other businesses to fill the half-empty plant. Moreover, Flanigan states that he will remove Bayer's sign at...

  • BAYER TO ACQUIRE VISIBLE GENETICS FOR $61.4 MILLION IN CASH.  // Worldwide Biotech;Sep2002, Vol. 14 Issue 9, p7 

    Highlights the acquisition deal between Bayer Diagnostics and Visible Genetics Incorporated.

  • Bayer Diagnostics Announces Ascensia Winner. Chanslor, J. // Diabetes Interview;Apr2004, Vol. 13 Issue 4, p14 

    Reports that Colleen McCarthy LaPierre won the first Ascensia Dream Fund Contest of Bayer Diagnostics in November 2004. Aim of the contest; Plans of LaPierre, a type 1 diabetes patient, for her award.

  • Two Classes of Lancing Devices.  // Diabetes Health;Dec2004, Vol. 13 Issue 12, p51 

    Presents several linear-motion and cam-driven lancing devices. Freestyle Lancing Device from Abbott Diabetes Care; Microlet Vaculance from Bayer Diagnostics; One Touch Penlet Plus from LifeScan.

  • Rolf Classon, president of Bayer Diagnostics, shares his views. Pontius, C. Anne // MLO: Medical Laboratory Observer;Sep2002, Vol. 34 Issue 9, p22 

    Interviews Rolf Classon, president of Bayer Diagnostics. Single factor which will have the most important impact on the diagnostic laboratory industry; Multiplexing technologies in molecular diagnostic applications such as oncology and pharmacogenomics; Role of computerization and the Internet...

  • New Products.  // Urologic Nursing;Oct2003, Vol. 23 Issue 5, p384 

    Reports developments related to medicine. Increase of the presence of Yamanouchi Pharmaceutical Co. Ltd. in pharmaceutical market; Result of the complexed prostate specific antigen test released by Bayer Diagnostics; Effectiveness of dietary supplement Prelief in improving quality of life for...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics